Korean Air Lines Co. will resume flights to Tianjin, northeast China, Tuesday after five months of suspension due to the pandemic.
The flights between Incheon and Tianjin will run every two weeks on Tuesdays in July and August and weekly beginning September.
With the resumption, Korean Air will be operating three routes connecting to Chinese cities, including Guangzhou and Shenyang.
Korean Air was hoping to double its weekly flights to Shenyang but failed to get approval from local authorities.
It, therefore, shifted to resuming the Tianjin flights.
To help balance passenger traffic loss during the pandemic, Korean Air shifted its efforts to cargo business, which moved it back to profitability.
According to Hanwha Investment & Securities analyst Kim Yoo-hyuk, Korean Air is expected to report a 149 billion won net profit in the second quarter.
The carrier absorbed a 736.86-billion-won net loss in the first quarter.


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



